# Clinical Evaluation of M22 ResurFX 1565nm Module

> **NCT01796626** · NA · COMPLETED · sponsor: **Lumenis Be Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Wrinkles
- Striae

## Interventions

- **DEVICE:** M22 ResurFX module

## Key facts

- **NCT ID:** NCT01796626
- **Lead sponsor:** Lumenis Be Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796626, "Clinical Evaluation of M22 ResurFX 1565nm Module". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01796626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*